Waldman Reid Alexander — SEC Form 4 filings

SEC reporting owner CIK 2107415. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2026-02-05 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Veradermics, Inc (MANE)Chief Executive Officer, Director25 legs · 67,500 sh · $7,280,7135
ACHIEVE LIFE SCIENCES, INC. (ACHV)Director23

Form 4 filings — Waldman Reid Alexander

FiledFormIssuerReported transactionsSource
2026-08-184Veradermics, Inc (MANE)Option exercise (M): 3,452 @ $12.19 · Sale (S): 11,527 @ $106.72 · Sale (S): 25,234 @ $107.53 · Sale (S): 27,490 @ $108.45 · Sale (S): 3,000 @ $109.38 · Sale (S): 249 @ $111.28 · +1 moreEDGAR
2026-07-294ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 16,700 (derivative) @ $0EDGAR
2026-06-024ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 47,250 (derivative) @ $0EDGAR
2026-02-054Veradermics, Inc (MANE)Conversion (C): 1,437 · Conversion (C): 1,437 (derivative) · Grant/award (A): 556,399 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2107415 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →